|
山东新华制药股份有限公司 - H股, 00719.HK - 综合现金流量表 |
2022-12 |
2021-12 |
2020-12 |
2019-12 |
2018-12 |
2017-12 |
2016-12 |
2015-12 |
2014-12 |
2013-12 |
2012-12 |
2011-12 |
2010-12 |
2009-12 |
2008-12 |
2007-12 |
2006-12 |
2005-12 |
经营活动之现金流量 |
824,487 |
303,620 |
538,442 |
535,520 |
525,028 |
610,920 |
642,162 |
557,922 |
413,533 |
158,609 |
128,358 |
172,235 |
185,417 |
377,222 |
254,344 |
105,577 |
92,530 |
216,982 |
投资回报及融资费用之现金流量 |
-190,153 |
-148,433 |
-143,287 |
-110,324 |
-103,810 |
-57,359 |
-94,257 |
-88,458 |
-85,566 |
-87,769 |
-78,476 |
-46,729 |
-28,844 |
-26,963 |
-24,242 |
-16,457 |
-27,653 |
-10,409 |
已收利息 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
4,811 |
3,674 |
3,020 |
2,206 |
2,631 |
1,929 |
3,617 |
3,958 |
9,721 |
11,757 |
已付利息 |
0 |
0 |
0 |
0 |
0 |
-54,414 |
-70,111 |
0 |
-79,243 |
-75,692 |
-57,729 |
-27,971 |
-18,889 |
-19,101 |
-17,956 |
-12,183 |
-20,475 |
-22,166 |
已收股息 |
0 |
0 |
0 |
7,514 |
0 |
0 |
0 |
0 |
4,137 |
3,898 |
2,572 |
1,899 |
5,994 |
5,549 |
4,022 |
914 |
141 |
0 |
已付股息 |
-190,153 |
-148,433 |
-143,287 |
-117,838 |
-103,810 |
-2,945 |
-24,146 |
-88,458 |
-15,271 |
-19,649 |
-26,339 |
-22,863 |
-18,580 |
-15,340 |
-13,925 |
-9,146 |
-17,040 |
0 |
其他 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
退回/(已缴)税项 |
-66,246 |
-44,503 |
-118,255 |
-187,249 |
-180,419 |
-220,948 |
-202,814 |
-209,286 |
-24,385 |
-16,839 |
-10,842 |
-25,055 |
-30,041 |
-13,393 |
-11,915 |
-11,510 |
-8,200 |
-5,388 |
投资活动之现金流量 |
-228,902 |
-237,694 |
-298,005 |
-420,454 |
-398,350 |
-168,537 |
-243,293 |
-110,176 |
-449,223 |
-402,885 |
-535,174 |
-448,868 |
-205,627 |
-268,187 |
-312,008 |
24,473 |
-40,853 |
-46,301 |
增添固定资产 |
-244,758 |
-249,227 |
-280,188 |
-366,512 |
-385,986 |
-261,108 |
-227,068 |
-169,086 |
-85,790 |
-68,332 |
-67,327 |
-444,758 |
-168,941 |
-194,760 |
-251,448 |
-112,344 |
-72,225 |
-109,751 |
出售固定资产 |
7,938 |
2,428 |
3,594 |
2,825 |
6,511 |
53,345 |
5,922 |
33,278 |
4,725 |
60,103 |
76,095 |
1,695 |
7,132 |
2,527 |
1,955 |
12,545 |
8,624 |
16,546 |
投资增加 |
0 |
0 |
-30,000 |
-56,767 |
-19,629 |
0 |
-30,000 |
0 |
-102,000 |
0 |
-22,000 |
0 |
0 |
-636 |
-4,770 |
-12,823 |
-13,000 |
-10,000 |
投资减少 |
0 |
0 |
8,589 |
0 |
7,155 |
9,227 |
7,853 |
20,334 |
2,280 |
0 |
0 |
11,613 |
518 |
569 |
-70 |
127,600 |
0 |
71,707 |
与关联人士之现金流量 |
37,380 |
17,400 |
33,000 |
0 |
46,943 |
0 |
0 |
0 |
13,000 |
199,300 |
508,500 |
0 |
0 |
2,432 |
0 |
-6,969 |
3,003 |
0 |
其他 |
-29,462 |
-8,295 |
-33,000 |
0 |
-53,344 |
29,999 |
0 |
5,298 |
-281,438 |
-593,956 |
-1,030,442 |
-17,418 |
-44,336 |
-78,319 |
-57,675 |
16,464 |
32,745 |
-14,803 |
融资活动前之现金流量 |
339,186 |
-127,010 |
-21,106 |
-182,507 |
-157,551 |
164,076 |
101,798 |
150,001 |
-145,641 |
-348,884 |
-496,134 |
-348,417 |
-79,095 |
68,679 |
-93,821 |
102,083 |
15,824 |
154,884 |
融资活动之现金流量 |
59,496 |
8,703 |
178,324 |
71,607 |
148,340 |
32,127 |
19,233 |
-75,091 |
136,303 |
245,407 |
603,712 |
248,313 |
82,767 |
112,052 |
77,655 |
-35,384 |
-180,732 |
-137,316 |
新增贷款 |
833,788 |
551,409 |
426,569 |
1,233,791 |
462,143 |
1,354,000 |
910,000 |
923,111 |
711,094 |
735,672 |
576,530 |
564,940 |
180,000 |
350,000 |
439,409 |
299,237 |
323,011 |
487,989 |
偿还贷款 |
-888,672 |
-559,739 |
-729,656 |
-1,103,000 |
-267,838 |
0 |
-1,087,800 |
-939,689 |
-627,791 |
-790,056 |
-550,481 |
-352,000 |
-97,233 |
-240,380 |
-361,754 |
-327,652 |
-506,746 |
-625,305 |
定息/债项工具融资 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
偿还定息/债项工具 |
0 |
0 |
0 |
0 |
0 |
-1,551,500 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
股本融资 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
与关联人士之现金流量 |
37,380 |
17,400 |
33,000 |
0 |
46,943 |
0 |
0 |
0 |
13,000 |
199,300 |
508,500 |
0 |
0 |
2,432 |
0 |
-6,969 |
3,003 |
0 |
其他 |
77,000 |
-367 |
448,411 |
-59,184 |
-92,908 |
229,627 |
197,033 |
-58,513 |
40,000 |
100,491 |
69,163 |
35,373 |
0 |
0 |
0 |
0 |
0 |
0 |
现金及等同现金之增加/(减少) |
398,682 |
-118,307 |
157,218 |
-110,900 |
-9,211 |
196,203 |
121,030 |
74,911 |
-9,338 |
-103,477 |
107,578 |
-100,104 |
3,672 |
180,731 |
-16,166 |
66,699 |
-164,908 |
17,568 |
年初之现金及现金等同项目 |
596,392 |
722,563 |
577,625 |
687,243 |
682,863 |
493,093 |
366,639 |
281,435 |
311,026 |
414,488 |
267,966 |
368,070 |
364,398 |
183,667 |
199,833 |
133,134 |
298,042 |
280,474 |
外汇兑换率变动之影响/(其他) |
15,691 |
-7,865 |
-12,280 |
1,281 |
5,807 |
-6,433 |
5,423 |
10,293 |
-9 |
15 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
年终之现金及现金等同项目 |
1,010,764 |
596,392 |
722,563 |
577,625 |
679,458 |
682,863 |
493,093 |
366,639 |
301,679 |
311,026 |
375,544 |
267,966 |
368,070 |
364,398 |
183,667 |
199,833 |
133,134 |
298,042 |
货币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
单位 |
千 |
千 |
千 |
千 |
千 |
千 |
千 |
核数师意见 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
说明:1代表无保留意见;2代表保留意见;3代表修改意见
|
|